Enhertu's Triumph: AstraZeneca and Daiichi Sankyo Unveil Pivotal Phase 3 Data, Reshaping Cancer Care
Breakthrough in Breast Cancer Treatment: Kelun Biotech's Sacituzumab Tirumotecan Shines at ESMO 2025
A New Dawn in Lung Cancer Treatment: Gilead and Arcus's Investigational Therapy Shows Promising Survival Advantage
GC Biopharma Unlocks New Hope: Landmark Phase 3 Trial for Barycela Kicks Off in Thailand